a comprehensive study 0/ - home - springer978-1-349-117… · · 2017-08-27a comprehensive study...
TRANSCRIPT
A Comprehensive Study 0/ Government Policy, R & D and Industry
Robert T. Yuan Mark D. Dibner
M
JAPANESEBIOTECHNOLOGY
© Robert T. Yuan and Mark D. Dibner, 1990 Softcover reprint of the hardcover 1 st edition 1990 978-0-333-53148-8
All rights reserved. No reproduction, copy or transmission of this publication may be made without written permission.
No paragraph of this publication may be reproduced, copied, or transmitted save with written permission or in accordance with the provisions of the Copyright Act 1956 (as amended).
Any person who does any unauthorised act in relation to this publication may be liable to criminal prosecution and civil claims for damage.
First published by MACMILLAN PUBLISHERS LTD, 1990
Distributed by Globe Book Services Ltd BruneI Road, Houndmills Basingstoke, Hants RG21 2XS
British Library Cataloguing in Publication Data
Yuan, Robert T. Japanese Biotechnology 1. Japan. Biotechnology I. Title. II. Dibner, Mark D. (Mark Douglas) 1951-660.60952
ISBN 978-1-349-11764-2 ISBN 978-1-349-11762-8 (eBook) DOI 10.1007/978-1-349-11762-8
C 0 N T E N T S
Contents ......................................................... v
List of Tables and Figures ............................................ vii
F oreword . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IX
Preface .......................................................... xiii
Exchange Rates .................................................... xv
Chapter 1. Executive Summary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Chapter 2. Introduction ............................................. 15
Chapter 3. Government Policy ........................................ 18
Chapter 4. Universities and Research Institutes. . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Chapter 5. The Japanese Biotechnology Industry . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
Chapter 6. Technology Transfer ....................................... 166
Chapter 7. Finance................................................. 175
Chapter 8. Doing Business in Japan .................................... 181
Chapter 9. COnclusions................................................ 189
List of Organizations and Individuals Visited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
v
Japanese Biotechnology
Appendix A: Guidelines for Recombinant DNA Experiments in Universities and Other
Research Institutes ............................................ 207
Appendix B: MITl's Regulations for Large-Scale Industrial Processes . . . . . . . . . . . . 245
Appendix C: Full Text of Notification of Application Data for Recombinant DNA
Drugs ...................................................... 261
Appendix D: Guidelines for Manufacturing Drugs Etc. by Application of Recombinant
DNA Technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 270
Appendix E: Guidelines for the Application of Recombinant DNA Organisms in
Agriculture, Forestry, Fisheries, the Food Industry and Other Related
Industries in Japan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 286
Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315
vi
L IST A N 0
OFT A B L E S F I GUR E S
Table 1. 1989 Japanese Government Budgets for Biotechnology R&D . . . . . . . . . . .. 24
Table 2. Japan Health Sciences Foundation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28
Table 3. Activities of Science and Technology Agency ........................ 31
Table 4. Budget for Life Sciences Programs of ST A . . . . . . . . . . . . . . . . . . . . . . . . . .32-33
Table 5. 1989 Budget of Research Development Corporation of Japan ........... 36
Table 6. ERA TO Projects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39-40
Table 7. AIST Biotechnology-Related Projects . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 50
Table 8. Budget for MAFF Biotechnology Programs ......................... 57-58
Table 9. 1989 Budget of Government-Industry Research Programs . . . . . . . . . . . . . .. 67
Table 10. Key Researchers at Three Selected Japanese Universities . . . . . . . . . . . . . .. 72
Table 11. Laboratories with Biotechnology-Related Projects, Kyoto University . . . . . . . 73
Table 12. Research at the Institute for Molecular and Cell Biology, Osaka University .. 75-76
Table 13. Research Projects of Biosensor and Bioelectronics Laboratory ........... 79
Table 14. Principal Government Research laboratories Involved in Biotechnology .... 81
Table 15. RIKEN Biotechnology-Related Laboratories, Wako Facility ............. 83-84
Table 16. Research Groups at RIKEN's Tsukuba Life Science Center .. . . . . . . . . . . . 85
Table 17. RIKEN - Division of Life Science Promotion Program Areas ............ 87
Table 18. Frontier Research Program - Bio-Homeostasis Program . . . . . . . . . . . . . . .. 88
Table 19. Tsukuba Research Consortium ................................... 90-91
Table 20. Member Companies of Protein Engineering Research Institute . . . . . . . . . .. 93
Table 21. Organization of Protein Engineering Research Institute ................ 94
Table 22. Organization of Osaka Bioscience Institute . . . . . . . . . . . . . . . . . . . . . . . . .. 96
Table 23. Primary Industry Focus of Japanese Biotechnology Companies - 1989 . . . . .. 111
Table 24. Primary Biotechnology Focus of Japanese Biotechnology Companies - 1989 . 120
vii
Japanese Biotechnology
Figure 1. Organization of Biotechnology within the Japanese Government . . . . . . . . .. 25
Figure 2. Structure of the Ministry of Health and Welfare . . . . . . . . . . . . . . . . . . . . .. 25
Figure 3. Structure of the Science and Technology Agency ..................... 34
Figure 4. Structure of the Ministry of International Trade and Industry . . . . . . . . . . .. 47
Figure 5. Map of Technopolis Areas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53
Figure 6. Structure of the Ministry of Agriculture, Forestry and Fisheries .......... 55
Vlll
FOREWORD
Japanese Biotechnology is part of a continuing series on international biotechnology. Earlier
volumes have examined biotechnology in Western Europe; Singapore, South Korea and Taiwan;
and the People's Republic of China and Hong Kong.
This study has been supported by:
Office of the Vice-Chancellor for Agricultural Affairs, University of Maryland
N orth Carolina Biotechnology Center
IC2 InstitutelRGK Foundation, Austin, TX
KPMG Peat Marwick, Oakland, CA
Office of Biotechnology, Iowa State University
State of Iowa, Department of Economic Development
State of Maryland, Office of International Trade
University of Iowa
Dr Robert Yuan is Professor of Microbiology at the University of Maryland at College Park,
MD. He is also director of BioTechnology International, a program of the International
Development Management Center. He has done extensive research in molecular biology, which
included appointments at the University of Edinburgh and at the Biozentrum of the University
of Basel, Switzerland. He has also served as First Secretary to the American Embassy in London,
and has carried out aseries of biotechnology assessments in Europe and Asia for the U .S.
International Trade Administration (Biotechnology in Western Europe; Biotechnology in Singapore,
South Korea and Taiwan; and Biotechnology in the People's Republic 01 China and Hong Kong).
He has also carried out a number of private studies for foreign governments and multinational
companies. He is multilingual and is familiar with the culture and customs of many European and
Asian countries.
IX
Japanese Biotechnology
Dr Mark D. Dibner is direetor of the Bioteehnology Information Division of the North
Carolina Bioteehnology Center. He is also Adjunet Associate Professor at Duke University's
Fuqua Sehool of Business, where he teaehes management of teehnology. In addition, he has
served as Chairman of the Couneil of Bioteehnology Centers, anational organization. He holds
a Ph.D. in neurobiology and behavior from Cornell University and an M.B.A. in strategie planning
from Widener University. He has written manyarticles on the bioteehnology industry and has
eonsulted and leetured in the United States and abroad on eommercial bioteehnology. Dr Dibner
is the author of Biotechnology Japan; Biotechnology Guide U.SA.: Companies, Data and Analysis;
and Basic Methods in Molecular Biology.
x
Foreword
BioTechnology International
BioTechnology International (BTI) is a program at the University of Maryland. The objectives
of BTI are:
o to carry out technical and industrial assessments of biotechnology worldwide;
o to organize workshops and symposia to promote the commercialization of biotechnology;
o to assist U .S. biotechnology companies in developing commercial ventures abroad.
BTI has carried out aseries of major biotechnology studies in Asia:
o Biotechnology in the People's Republic of China and Hong Kong (funded by the U.S.
Department of Commerce, the Maryland Office of International Trade, and the College
of Agriculture, University of Maryland, College Park;
o Biotechnology in Asia: A Financial Perspective, in collaboration with Mr Michael Hsu,
president of Asia/Pacific Strategic Bioventures (funded by the U.S. Congressional Office
of Technology Assessment).
In addition, Dr. Yuan, director of BTI, has carried out detailed studies of biotechnology in eleven
countries of Western Europe. BTI helped organize the first conference on Biotechnology in the
Pacific Rim which was held in Singapore on September 1988.
BTI is currently carrying out a study for the Hong Kong government to determine the
feasibility of a biotechnology industry in Hong Kong and a study for the Royal Thai Government
on the commercial opportunities for biotechnology in Thailand. Among other projects, BTI is
involved in the organization of the U.S. and Asian Pacific Biotech Conference '90 to be held in
Houston and focusing on collaboration and commercialization of biotechnology, and a workshop
on the Financing of Biotechnology in the Pacific Rim.
BTI has elose relationships with foreign governments, state economic development agencies,
industrial associations, and biotechnology companies both in the United States and abroad.
Xl
Japanese Biotechnology
Tbc North Carolina Biotechnology Center
Tbe North Carolina Biotechnology Center was established in 1981 to catalyze economic
development in North Carolina through support of biotechnology. Largely funded by the State
of North Carolina, the Center is a private, non-profit corporation. In addition to the Information
Division, other Center programs include grants to universities and small companies, public
education, special focus groups, and economic development.
Tbe Biotechnology Information Division of the North Carolina Biotechnology Center was
started by Dr Dibner in 1986 to compile and make available data on commercial biotechnology -
- in North Carolina, in the United States, and worldwide. Tbrough a multi-faceted approach of
utilizing a commercial biotechnology-oriented library, paper datafiles, in-house computer databases
(on U.S. companies and partnering in biotechnology worldwide) and commercially available
databases, the Division is able to provide information to a variety of users. Reports from the
Division's databases are made available to individuals, companies, organizations, and govemment
agencies on a contractual, cost recovery basis. Oients for larger studies have included the Office
of Technology Assessment, the U.S. Department of Agriculture, the U.S. Environmental
Protection Agency, the National Science Foundation, the Association ofBiotechnology Companies,
and several foreign govemments. Tbe Division has recently created a new database of Japanese
companies working with biotechnology, now ready for client use.
xii
P R E F ACE
This report is one in aseries of technical and industrial assessments of biotechnology in the major
industrialized nations of Western Europe and the Far East. Its objectives are to:
odetermine government policies in support of biotechnology;
o identify principal research laboratories and their activities;
o identify principal companies involved in biotechnology and their activities;
o study the various mechanisms for technology transfer from research laboratories to the
industrial sector;
o provide useful information for those biotechnology companies and organizations interested
in doing business in Japan.
The procedure used in this study closely follows the one established for earlier projects in
Western Europe and Asia. Lists of organizations and individuals were obtained from four
different sources: a) colleagues in the scientific community, b) the American Embassy in Tokyo
and the Tokyo Office of the Maryland Office of International Trade, c) the North Carolina
Biotechnology Center's Japan Database, and d) officials in the Japanese government. These lists
were cross-checked against one another and against published reports and articles. Extensive
reading of published materials and selected briefings occurred prior to the site visits arranged by
the American Embassy in Tokyo. The meetings on-site provided an opportunity to obtain current
documents (some in Japanese) and these documents and notes were used in the preparation of
a preliminary report. More extensive work was required for the preparation of this report, which
was reviewed by the staff of the Science Office and Foreign Commercial Service at the American
Embassy in Tokyo and selected other individuals who are knowledgeable about the state of
Japanese biotechnology. Corrections and comments were incorporated prior to the preparation
of the final report.
xiii
Japanese Biotechnology
The Japan project was carried out over the period from May 1989 to May 1990. It is highly
unusual because it involves the collaboration of diverse institutions, such as the federal
government, universities, state economic development agencies, a private foundation, and a private
financial organization. It could not have been possible without the enthusiastic cooperation of the
Japan Desk at the State Department, the American Embassy in Tokyo, and hosts of Japanese
officials, scientists, and corporate managers.
The authors are particularly indebted to Dr Daniel Hamilton and Ms Diane Plentovich of
BioTechnology International and Mr R. Steven White of the Sumitomo Corporation for their
research and logistical support. The authors would also like to express their gratitude to the
following individuals for their encouragement and generous assistance:
xiv
Dr Kenneth Chern, Japan desk, U.S. Department of State
Mr Genya Chiba, ERATO, Japan Research Development Corporation
Dr Robert Fujimura, Oak Ridge National Laboratory
Mr Michael Grose, Maryland Office of International Trade, Tokyo
Dr Marcus Ingle, International Development Management Center, University of Maryland
Ms Kathryn D. Lindquist, Maryland Office of International Trade
Dr. George Kozmetsky, RGK Foundation, Austin, TX
Mr Robert Ludan, American Embassy, Tokyo
Ms Christina Lowell, KPMG Peat Marwick, Oakland, CA
Dr Kenichi Matsubara, Osaka University
Dr Raymond Miller, Vice-Chancellor for Agricultural Affairs, University of Maryland
Ms Fumiko Shioda, American Embassy, Tokyo
Dr Steven Price, Iowa State University
Dr Henry Miller, U.S. Food and Drug Administration
Dr Raymond Smilor, I~ Institute, Austin, TX
Dr Charles E. Hammer, Jr., North Carolina Biotechnology Center
Ms. Janet Hafer, North Carolina Biotechnology Center
Mr John Sylvester, North Carolina Japan Center
Mr Harold Zassenhaus, Maryland Office of International Trade
E X C H A N G E RAT E S
Because the exchange rate between the Japanese yen and the V.S. dollar has fluctuated in the
past years, in this report we have used the rates listed below.
Year
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
Yen per US $
226.74
220.54
249.08
237.51
237.52
238.54
168.52
144.64
128.15
137.96
Reference: International Financial Statistics, International Monetary Fund 1989 Yearbook.
xv